Outcomes and Readmissions After Continuous Flow Left Ventricular Assist Device: Heartmate II Versus Heartware Ventricular Assist Device


Tuncer O. N. , KEMALOĞLU C., ERBASAN O., GÖLBAŞI İ., TÜRKAY C., BAYEZİD Ö.

TRANSPLANTATION PROCEEDINGS, vol.48, no.6, pp.2157-2161, 2016 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 48 Issue: 6
  • Publication Date: 2016
  • Doi Number: 10.1016/j.transproceed.2016.03.056
  • Title of Journal : TRANSPLANTATION PROCEEDINGS
  • Page Numbers: pp.2157-2161

Abstract

Introduction. Donor organ shortage is still a problem for heart transplantation. Only 10% of patients in waiting list undergo heart transplantation. Over the last 5 years, 2 different continuous flow pumps, the HeartMate II and the HeartWare, have been successful clinically in the alternative treatment of patients with end-stage heart disease.